Ketamine Produces Lasting Disruptions in Encoding of Sensory Stimuli
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A review of the evidence for P2 being an independent component process: Age, sleep and modality
Crowley, K. E., & Colrain, I. M. (2004) · Clinical Neurophysiology · doi:10.1016/j.clinph.2003.11.021 · Cited by 853 · cited 1×
“Although this is a concern in most AEP studies, some investigators have made an effort to describe the P2 as an independent component (Crowley and Colrain, 2004).”
BackgroundCircuit analysis of NMDAR hypofunction in the hippocampus, in vitro, and psychosis of schizophrenia†
Greene, R. (2001) · Hippocampus · doi:10.1002/hipo.1072 · Cited by 140 · cited 1×
“Several investigators have proposed that reduced function at N-methyl-D-aspartate receptors may precede overt manifestations of schizophrenia (Newcomer et al., 1999; Greene, 2001).”
Background
Cited by
Koike, H., Iijima, M., & Chaki, S. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.05.035 · Cited by 346
Neurophysiological biomarkers for drug development in schizophrenia
Javitt, D. C., Spencer, K. M., Thaker, G. K., Winterer, G., & Hajós, M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2463 · Cited by 342
Prolonged exposure to ketamine increases neurodegeneration in the developing monkey brain
Zou, X., Patterson, T. A., Divine, R. L., Sadovova, N., Zhang, X., Hanig, J. P., Paule, M. G., Slikker, W., & Wang, C. (2009) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2009.06.010 · Cited by 260
Sinclair, D., Oranje, B., Razak, K. A., Siegel, S. J., & Schmid, S. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.05.029 · Cited by 198
“However, it decreases rather than increases N1 latency (Connolly et al., 2004; Maxwell et al., 2006) and increases rather than decreases evoked gamma power (Lazarewicz et al.”
Self-citationFukumoto, K., Fogaça, M. V., Liu, R.-J., Duman, C., Kato, T., Li, X.-Y., & Duman, R. S. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1814709116 · Cited by 188
“(2R,6R)-HNK is rapidly eliminated from the brain within hours (9, 47), even though it produces long-lasting antidepressant actions for up to 3 to 5 d as shown in the current study.”
BackgroundPham, T. H., & Gardier, A. M. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.02.017 · Cited by 186
“Ketamine has a short elimination half-life (t1/2 = 30 min in mice; (Maxwell et al., 2006)) and is rapidly transformed into various metabolites such asnorketamine andHNKs immediately after it enters the body circulation (Can et al.”
BackgroundMouse behavioral endophenotypes for schizophrenia
Amann, L. C., Gandal, M. J., Halene, T. B., Ehrlichman, R. S., White, S. L., McCarren, H. S., & Siegel, S. J. (2010) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2010.04.008 · Cited by 180
Self-citationTranslating Glutamate: From Pathophysiology to Treatment
Javitt, D. C., Schoepp, D., Kalivas, P. W., Volkow, N. D., Zarate, C., Merchant, K., Bear, M. F., Umbricht, D., Hajos, M., Potter, W. Z., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002804 · Cited by 168
Assessment of NMDA receptor NR1 subunit hypofunction in mice as a model for schizophrenia
Halene, T. B., Ehrlichman, R. S., Liang, Y., Christian, E. P., Jonak, G. J., Gur, T. L., Blendy, J. A., Dow, H. C., Brodkin, E. S., Schneider, F., et al. (2009) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2009.00504.x · Cited by 161
“Our group has previously shown that a repetitive dose of 5 mg/kg ketamine causes long-term adaptation of ERPs and hippocampal cell death (Majewski-Tiedeken et al. 2007; Maxwell et al. 2006).”
BackgroundMethodSelf-citationPham, T. H., Mendez-David, I., Defaix, C., Guiard, B. P., Tritschler, L., David, D. J., & Gardier, A. M. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.05.010 · Cited by 136
Koike, H., Iijima, M., & Chaki, S. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.08.034 · Cited by 114
Zhang, Y., Behrens, M. M., & Lisman, J. E. (2008) · Journal of Neurophysiology · doi:10.1152/jn.00079.2008 · Cited by 107
Carlson, G. C., Talbot, K., Halene, T. B., Gandal, M. J., Kazi, H. A., Schlosser, L., Phung, Q. H., Gur, R. E., Arnold, S. E., & Siegel, S. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1109625108 · Cited by 103
Self-citationThe profile of cognitive impairments in chronic ketamine users
Ke, X., Ding, Y., Xu, K., He, H., Wang, D., Deng, X., Zhang, X., Zhou, Y., Zhou, C., Liu, Y., et al. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.05.050 · Cited by 67
Wang, X., Pinto-Duarte, A., Sejnowski, T. J., & Behrens, M. M. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4907 · Cited by 46
“3), were observed to vary in peak amplitude and latency in the time domain (3, 153) and to have stronger gamma-frequency components in the frequency domain (55, 129, 204).”
Rantamäki, T., & Kohtala, S. (2020) · Pharmacological Reviews · doi:10.1124/pr.119.018697 · Cited by 45
“These approaches have generally not accounted for the temporal gradients of molecular changes that may take place during acute pharmacological effects of ketamine and thereafter (t1/2 ;10–15 minutes in mice) (Maxwell et al., 2006).”
BackgroundJones, N. C., Hudson, M., Foreman, J., Rind, G., Hill, R., Manning, E. E., & van den Buuse, M. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.13722 · Cited by 20
“ERP components have been shown to be modified by NMDAR antagonists in mice (Maxwell et al., 2006) and by BDNF genetic variation in humans (Schofield et al., 2009).”
BackgroundThe NMDA receptor subunit GluN2D is a potential target for rapid antidepressant action
Vestring, S., Veleanu, M., Perez, M. C., Schuberth, L. E., Bronnec, M., Li, A., Würz, L. M., Erdogdu, F., Stocker, J., Moos, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-66774-w · Cited by 13
Metadata
- Authors
- Maxwell, C. R., Ehrlichman, R. S., Liang, Y., Trief, D., Kanes, S. J., Karp, J., & Siegel, S. J.
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 2006-01
- Volume
- 316
- Issue
- 1
- Pages
- 315-324
- ISSN
- 0022-3565 (ISSN-L)
- OpenAlex
- W2145936409
- Cited by
- 160
- References
- 2
- FWCI
- 2.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.